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All the clinical and pathologic features of malaria are solely attributable to the
parasitic stages of the asexual erythrocytic cycle . The propagation of this cycle in
ahost is dependent upon extracellular merozoites attaching to andinvading suscep-
tible erythrocytes . This attachment and initiation of invasion by malariamerozoites
is mediated through specific interactions betweenparasite receptors andligand mol-
ecules on the erythrocyte plasma membrane (1, 2) . The identification oferythrocyte
liganns used by invading merozoites is important to understanding this biologic event
at the molecular level . Furthermore, this knowledge can aid in the isolation ofmalaria
parasite receptor antigens ; potential targets of vaccine induced immunity.
Studies on Plasmodium knowlesi, a simian malaria that can invade human erythro-
cytes, have indicated that an erythrocyte membrane component associated with Duffy
blood group determinants is used by this species as a ligand for merozoite invasion
(3-5) . These studies on a simian malaria became more relevant to human malaria
when indirect and retrospective studies in vivo also correlated susceptibility to infec-
tion by Plasmodium vtvax, a human malaria parasite of major importance, with the
presence of the Duffy blood group antigens (6, 7) .
Direct ligand studies with P . vivaxcould not be done, however, because these para-
sites were difficult to obtain and could not be cultured in vitro, as has been possible
with Plasmodiumfalciparum andP . knowlesi . Here we describe a short term invasion
assay in vitro forP . vivax parasites obtained from squirrel (Saimiri sciureus) monkeys .
We have made use of this invasion assay to investigate the role of the Duffy blood
group as an erythrocyte ligand for P . vivaxmerozoites usinghumanandsimian erythro-
cytesofvarying Duffy phenotypes and amAb against a new Duffy blood group de-
terminant, Fy6 (8) .
Materials and Methods
Parasites and Cultures.
￿
P . knowlesi(H strain) parasites were cryopreserved in liquid nitrogen
as ring stage infected erythrocytes from rhesus monkeys (9) . Cryopreserved infected erythro-
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cytes for use in invasion assays in vitro were thawed and cultured to the schizont stage in
tissue culture medium RPMI 1640 supplemented with 30 mM Hepes, 2 g/liter D-glucose,
50 mg/liter hypoxanthine, and 15% horse serum (HyClone Laboratories, Losan, UT), or
15% human AB serum (complete medium) in an atmosphere of 5% C02/5% 02/90% N2
at 37°C for 18-20 h.
P. falciparum (FCR-3) parasites were cultured in vitro in human O' erythrocytes and
RPMI 1640 complete medium with 10% human serum (10). P. vzvax (Belem) parasites were
obtained from squirrel monkeys with synchronous infections when the majority of parasites
were at the trophozoite stage. The heparinized blood with added ADP (1 mg/ml) was passed
sequentially over acid-washed glass bead (0.11 mM diameter) and Whatman CFII cellulose
columns to remove platelets and leukocytes and then centrifuged on 54°70 Percoll (Pharmacia
Fine Chemicals, Piscataway, NJ) to concentrate parasitized erythrocytes to >90% purity (9).
Maturation ofthe parasites to mature schizonts was accomplished in RPMI 1640 supplemented
with hypoxanthine (50 mg/liter), D-glucose (2 g/liter) (HyClone Laboratories), Hepes or TES
(35 mM), 10% human AB serum, and 10% fetal calfor horse serum (HyClone Laboratories)
as above for P. knowlesi.
Invasion Assays.
￿
P . falciparum late trophozoite and early schizont infected erythrocytes were
concentrated to 80% parasitemia on plasmagel and adjusted to 108/ml in medium . Target
cells at 108/ml were mixed with parasitized erythrocytes at a ratio of 10:1 and cultured in
0.5 ml volumes in 24-well tissue culture plates. P . knowlesi schizont-infected erythrocytes were
concentrated to >95% parasitemia on a 54% Percoll cushion (9), adjusted to 5 x 107/ml,
mixed with target cells (5 x 10'/ml) at a 1 :10 ratio, and cultured in 0.5 ml medium volumes
in 24-well tissue culture plates. P. vivax schizont-infected erythrocytes were mixed with target
cells at 1 :5 to 1 :10 ratios at 5 x 107/ml and cultured as above. Uninfected erythrocytes for
use in P. vivax invasion assays were first processed on 62% Percoll cushions to increase the
percentage of reticulocytes. The less dense erythrocytes at the Percoll interface were used
as target cells in assays of invasion. P . falciparum cultures were harvested after 12 h for blood
film preparation. P. knowlesi and P. vivax cultures were harvested after 8-10 h. After Giemsa
staining of thin film smears, 1,000-2,000 erythrocytes were examined by light microscopy
and the number of ring stage parasites was determined. Smears of the infected erythro-
cytes/target cell mixtures were also made at the start of the invasion assays and the number
of ring stage parasites were determined. Any background invasion rates found in these wells
were subtracted from the invasion rates determined in the test wells after 8-12 h ofincubation.
mAbs and Target Erythrocytes.
￿
mAb K6H9 (BG6) recognizes a new determinant (Fy6) on
a 43-46-kD erythrocyte membrane component ofDuffy-positive erythrocytes that is unrelated
to the other recognized Duffy blood group antigen determinants Fya, Fyb, Fya, and Fy5 (8).
mAbs G10 and F7 recognize Kell blood group antigens K-14 and K-2 (k) that are on a 93-kD
erythrocyte membrane protein (10). mAb 10-22 recognizes a determinant on erythrocyte
glycophorin that is absent from En(a-) and Wr(b-) erythrocytes and mAb 4-21 recognizes
adeterminant that is absent from Wr(b-) but not En(a-) erythrocytes (Nichols, M., unpub-
lished data). All mAbs were nonagglutinating. Human antisera specific for Fya (titer 1 :256)
was obtained from Ortho Pharmaceuticals (Raritan, NJ) and absorbed with human Duffy-
negative erythrocytes before use. Fab fragments were obtained by treating affinity-purified
mAb K6H9 with cysteine-activated papain immobilized on agarose beads (Sigma Chemical
Co., St. Louis, MO). After digestion, the papain-treated supernatant was processed over a
MAPS protein A-affi gel column (Bio-Rad Laboratories, Richmond, CA) to remove the Fc
fragments. The Fab preparation of mAb BG6 wasjudged to be pure by SDS-PAGE and silver
strain analysis. Erythrocytes (2 x 109) were sensitized with 2 .0 ml of mAbs (25 wg anti-
body/ml) or 0.5 ml of human anti-Fya serum at 25°C for 1-2 h with mixing, washed twice
in tissue culture medium, and then used as target cells in invasion assays. Human erythro-
cytes and simian erythrocytes had been serotyped by M. E. Nichols at the New York Blood
Center.
Enzymatic Treatment of Erythrocytes.
￿
Erythrocytes (2 x 109) were pretreated with either
trypsin (0.5 mg), chymotrypsin (0.5 mg), or neuraminiciase (100 mU) for 1 h at 37°C. After
enzyme treatment erythrocytes were incubated for 10 min, in 1 ml PBS containing either
1 mg/ml soybean trypsin inhibitor or 5 mM chymostatin for the trypsin- or chymotrypsin-BARNWELL ET AL .
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treated erythrocytes, respectively and then washed three times in RPMI 1640 tissue culture
medium . Control erythrocytes were also incubated for 10 min in either soybean trypsin in-
hibitor or chymostatin. Neuraminidase (V . cholerae), trypsin, and chymotrypsin were pur-
chased from Calbiochem-Behring Corp ., San Diego, CA and inhibitors from Sigma Chem-
ical Co., St . Louis, MO.
Results
P . vivax trophozoite-infected erythrocytes were collected from squirrel monkeys
with synchronized infections and grown in vitro to fully developed mature schizonts
(Fig . 1) . Table I shows the results of four successful invasion trials where the in vitro
matured parasites were mixed with fresh human erythrocytes, recultured, and ex-
amined after an additional 8 to 10 hours . The percentage ofschizont-infected erythro-
cytes at this time has decreased with a corresponding increase in the percentage of
erythrocytes showing typical P . vivax young ring stage parasites (Fig . 1) . Generally,
the overall percent parasitemia has actually decreased at this time, but this is in-
cidental to the assessment of invasion that is made by enumeration ofnew ring stage
parasites . These results made it possible to study directly in vitro the role of Duffy
blood group antigens as a ligand for invasion by P . vivax merozoites .
Human Duffy-positive [Fy(a+b')] and human Duffy-negative [Fy(a-b -)] erythro-
cytes along with various simian erythrocytes were used as target cells for invasion
by P . vivaxand P . knowlesi merozoites in vitro . As shown in Table II, P . vivax invaded
the Fy6 positive erythrocytes of humans and both Saimiri and Aotus monkeys, but
not Fy6 - erythrocytes of humans and rhesus . As has been shown previously (12,
13), P . knowlesi invaded the Fy:b+,3+,6- erythrocytes of rhesus, as well as the Fy:6+
cells of Saimiri and Aotus, but not human Duffy-negative erythrocytes . A preference
for rhesus erythrocytes over human, Saimiri, and Aotus erythrocytes is shown for
P . knowlesi .
Treatment of Fy(a+b+) human erythrocytes with chymotrypsin abolished suscep-
tibility to invasion byP . vivax merozoites with a 91% decrease in invasion in compar-
ison to untreated control erythrocytes . Enzymatic treatment of the human Fy(a+b+)
erythrocytes with trypsin or neuraminidase had no effect on invasion . Similar results
were obtained for P . knowlesi as has been reported previously (3, 4) .
To further assess the possible role ofthe Duffy erythrocyte membrane component
TABLE I
In Vitro Invasion of Human Erythrocytes by P. vivax
Developmental stage' and total parasitemia
Immediately after addition
￿
8-10 h after addition of
of fresh RBCs
￿
fresh RBCs
' Sz, schizonts ; R, ring stages ; P, total parasitemia .
Exp . Sz R P Sz R P
1 88 1 9 .2 10 86 3 .6
2 96 1 11 .2 7 93 9 .6
3 82 1 14 .5 16 82 8 .7
4 95 2 12 .1 4 96 15 .01798 THE DUFFY BLOOD GROUP IN INVASION BY PLASMODIUM MAX
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TABLE II
Invasion of Human and Simian Erythrocytes of Defined Duffy Phenotype
by P. vivax and P. knowlesi Merozoites
TABLE III
Effect of mAbs to Duffy and Other Erythrocyte Antigens on Invasion of Human Erythrocytes
by P. vivax, P. knowlesi, and P. falciparum Merozoites
Calculated on the basis of ring stage parasitemias in control cultures with unsensitized target erythrocytes.
3 Number of individual experiments.
as a ligand for P. vivaxmerozoites we sensitized human Duffy-positive erythrocytes
[Fy(a+b+)] with mAb K6H9 (anti-Fy6) or, as controls, mAbs reactive with Kell (K2,
K14) or glycophorin [En(a), Wr(b)] determinants for use in invasion assays (Table
III). mAb K6H9 inhibited invasion of both P . vivax and P . knowlesi, 84 and 90%
respectively. The controlmAbs showed no significant inhibition ofinvasion of P. vivax
and P . knowlesi merozoites. Conversely, the anti-Fy6 mAb did not inhibit the inva-
sion of P. falciparum merozoites, whereas mAb 10-22 [anti-En(a)] did inhibit the in-
vasion of this Plasmodium species by 90%. Human Fy(a+b+) erythrocytes sensitized
with F(ab) fragments of mAb K6H9 also showed a decrease in invasion with both
P. vivax (88%) and P. knowlesi (84.4%).
mAb K6H9 also blocked invasion of P. vivax into Aotus erythrocytes and Saimiri
erythrocytes by 41% and 37.8%, respectively, whereas P. knowlesi invasion of Aotus
andSaimirierythrocytes was inhibited 34.2 and 84.7%, respectively. Anti-Fya human
serum partially inhibited P. vivax invasion of Fy(a+b+) and Fy(a+b-) human erythro-
cytes 39 and 52%, respectively. Invasion of Fy(a-b+) cells incubated with anti-Fya
serum was not significantly different from nonsensitized control cells.
Discussion
It has been hypothesized that P . vivax merozoites use a membrane component as-
sociated with theDuffyblood group as aligand to gain entryinto erythrocytes. Studies
on Duffy-negative (Fya-b-) individuals voluntarily inoculated with P. vivax
Duffy (Fy6)
Percent inhibition
Kell (K2)
of invasion' by
Kell (K14)
mAbs against:
Ena Wrb
Species of determinant determinant determinant determinant determinant
plasmodium (mAb BG6) (mAb F7) (mAb G10) (mAb 10-22) (mAb 4-21)
P. vivax 84 t 9 (4)1 - 5 t 6 (3) 5 t 4 (3) - 6 t 8 (2) 0 t 6 (2)
P. knowlesi 90 t 5 (4) 6 t 5 (3) - 2 t 6 (3) 7 t 4 (2) 10 t 8 (2)
P. falciparum - 7 1 3 (2) 7 1 3 (2) 18 1 13 (2) 88 1 4 (2) - 5 1 5 (2)
Erythrocytes
species Fya
Duffy
Fyb
phenotype
Fy3 Fy6
Invasion
P. vivax
rate
P. knowlesi
Human + + + + 8.7 12.8
Human - - - - 0 .1 0.2
Rhesus - + + - <0.1 27.4
Saimiri - - + + 7.8 8.3
Aotus - + + + 5 .1 6.91800
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sporozoites or living in areas of high endemnicity found that these subjects never
become infected with this human malaria species (6, 7). However, direct in vitro ex-
periments with P . vivax merozoites were not done as this human malaria parasite
could not be easily obtained nor cultured in vitro. We have recently developed a
short term in vitro invasion assay for P. vivaxand produced a mAb antibody, desig-
nated K6H9 (BG6), which recognizes an epitope, Fy6, that is unrelated to previ-
ouslyknownepitopes on the Duffy blood group antigen(8). Together, these develop-
ments provide the first direct evidence that the Duffy antigen does play a role in
the invasion of erythrocytes by P. vivax merozoites.
Three lines of evidence obtained in vitro indicate that the Duffy blood group an-
tigen serves as a host ligand. First, P . vivax did not invade human erythrocytes of
the Duffy-negative phenotype, while Duffy-positive erythrocytes were readily infected.
P. vivax also invaded the erythrocytes ofAotusand Saimiri (squirrel) monkeys in vitro
that lack Fya and/or Fyb Duffy determinants but carry the Fy6 and Fy3 deter-
minants on their cells (8, 12; Table II). In contrast, rhesus erythrocytes which are
Fyb and Fy3', but lack the Fy6 epitope, are not invaded by P. vivax. Second, treat-
ment of Duffy-positive erythrocytes with chymotrypsin, which removes the Duffy
determinants Fya, Fyb, Fy6, but not Fy3, inhibits invasion by P . vivax. Trypsiniza-
tion of human Duffy-positive erythrocytes does not remove any Duffydeterminants
and does not inhibit P. vivax invasion.
Third, antibody-mediated inhibition of invasion by mAb K6H9 provided direct
evidence that the Duffy antigen serves as aligand forP. vivaxmerozoites. mAbK6H9
inhibited invasion by both P. vivax and P . knowlesi, while mAbs against Kell or
glycophorin blood groupdeterminants did not block invasion. In addition, theanti-
Fy6 mAbdid not inhibitP . falcilbarum merozoiteinvasion. This malaria parasite uses
glycophorin as a ligand and invasion was inhibited by the antiglycophorin mAb 10-
22. These results indicated the blockage ofinvasion by mAbK6H9 was specific and
did not result from a nonspecific event such as increased erythrocyte membrane ri-
gidity produced by molecular crosslinking (3). Also, since the quantity of Duffy an-
tigen exposed on the erythrocyte surface (12,000 specific antigen sites) is low (8) it
is not likely that antibody blockade resulted by preventing themerozoite from inter-
acting with anotherligand in the membrane. The specificity of the antibody blockade
wasfurther confirmedby an equal inhibition of P. vivaxandP . knowlesi invasion when
either intact or F(ab) fragments of anti-Fy6 mAb are used.
The data presented here show that P. vivax merozoites use the Duffy glycoprotein
(14) as a ligand during the process of invasion. Additionally, previous correlative
data in vivo (8) and the in vitro results indicate that the Fy6 epitope or a nearby
domain may be the functional site of interaction on the Duffy glycoprotein and a
merozoite receptor protein. However, the Duffyligand probably is not theonly eryth-
rocyte component required for P . vivax merozoite invasion of erythrocytes. P. vivax
shows a very strong predilection for invading reticulocytes even though the Duffy
glycoprotein is also present on mature erythrocytes. Thus, P. vivax may require at
least two.ligands, the Duffy antigen, and a separate component or characteristic of
reticulocytes for the efficient invasion ofhuman erythrocytes. The latter component
of reticulocytes could function in initial merozoite attachment whereas the Duffy
glycoprotein may be involved in junction formation (15, 16).
Furthermore, the partial inhibition of invasion (40%) of P. vivax into Aotus andBARNWELL ET AL.
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Saimiri erythrocytes by the anti-Fy6 mAb may even indicate an alternate mecha-
nism of invasion by P. vivax in the case of simian erythrocytes. Evidence for the exis-
tence of alternate ligands and multiple receptors are known for P. knowlesi (5) and
has been recently documented for P. falciparum (17, 18).
The Duffy Fya determinant, and now a new determinant, Fy6, have been local-
ized to an erythrocyte membrane component, a glycoprotein, of -43 kD (8, 14).
Further studies on both the Duffy glycoprotein and the merozoite are needed to
more accurately define the molecular interactions that occur during the invasion
oferythrocytes by P vivax and P . knowlesi. Identification ofthe corresponding merozoite
Duffy receptor(s), potential immunogens in the development of a malaria vaccine,
will be essential in defining the mechanism(s) of merozoite erythrocyte invasion at
the molecular level.
Summary
A short-term in vitro culture system that allows for significant re-invasion oftarget
erythrocytes by Plasmodium vivax was used to study the role ofthe Duffy blood group
antigen as a ligand for merozoite invasion by this human malaria species. Using
human Duffy-positive and -negative erythrocytes, various primate erythrocytes, en-
zymatic modification oferythrocytes, and mAb that defines a new Duffy determinant
(Fy6) we conclude that the erythrocyte glycoprotein carrying Duffy determinants
is required as a ligand for the invasion ofhuman erythrocytes by P. vivax merozoites.
Blockade of invasion by Fab fragments of the anti-Fy6 mAb equal to that of the
intact molecule and the correlation of P. vivax susceptibility with the presence of
the Fy6 determinant suggests this epitope or a nearby domain may be an active site
on the Duffy glycoprotein . However, as for P. knowlesi, there is evidence that an al-
ternate pathway for P. vivax invasion of simian erythrocytes may exist.
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